Skip to main content

Table 3 Results of meta-analyses

From: Costs of multimorbidity: a systematic review and meta-analyses

Dyad Pooled mean cost (I$) 95%CI
Hypertension + Musculoskeletal disorder 13,270 (12,960–13,580)
Hypertension + Diabetes 14,300 (13,940–14,660)
Hypertension + Respiratory condition 17,180 (16,530–17,830)
Hypertension + Kidney disease 17,740 (17,060–18,420)
Hypertension + Heart/vascular condition 17,880 (17,520–18,250)
Diabetes + Mental health condition 20,750 (19,830–21,660)
Diabetes + Kidney disease 32,410 (32,370–32,440)
Respiratory + Heart/vascular condition 35,070 (34,890–35,260)
Respiratory + Mental health condition 36,840 (36,440–37,250)
Diabetes + Heart/vascular condition 37,090 (35,870–38,310)
Cancer + Mental health condition (first year after cancer diagnosis) 85,820 (81,930–89,690)
  1. Legend: Mean cost data were meta-analyzed using a fixed-effects model assuming a normal likelihood for study-specific mean costs. All meta-analyses resulted in I2 values above 95%. Costs are presented in 2021 International Dollars